Are you Dr. Deftereos?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
San Francisco, CA 94143Phone+1 415-353-7043Fax+1 415-353-7676
Summary
- Dr. Georgios Deftereos, MD is a board certified pathologist in San Francisco, California. He is currently licensed to practice medicine in California, Texas, and Colorado. He is affiliated with Kaiser Permanente San Francisco Medical Center and UCSF Medical Center.
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH)Residency, Pathology-Anatomic and Clinical, 2010 - 2014
- University of Bari Faculty of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2022 - 2026
- TX State Medical License 2018 - 2024
- UT State Medical License 2016 - 2024
- CO State Medical License 2017 - 2023
- PA State Medical License 2010 - 2022
- WA State Medical License 2014 - 2022
- OH State Medical License 2012 - 2013
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.Cameron Beech, Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow
Applied Immunohistochemistry & Molecular Morphology. 2025-01-27 - A Pipeline for Evaluation of Machine Learning/Artificial Intelligence Models to Quantify Programmed Death Ligand 1 Immunohistochemistry.Beatrice S Knudsen, Alok Jadhav, Lindsey J Perry, Jeppe Thagaard, Georgios Deftereos
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2024-06-01 - Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer.Diane M Wilcock, Kristina H Moore, Leslie Rowe, Jonathan Mahlow, Jolanta Jedrzkiewicz
Archives of Pathology & Laboratory Medicine. 2023-12-01